Proteomic analysis of undiluted lung epithelial lining fluid

Chest

Volumn 134, Issue 2, 2008, Pages 338-345

  Kipnis, Eric ^d   Hansen, Kirk ^c   Sawa, Teiji ^b   Moriyama, Kiyoshi ^b   Zurawel, Ashley ^c   Ishizaka, Akitoshi ^e   Wiener Kronish, Jeanine ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIV LILLE   (France)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Biomarker; Lung disease; Mass spectrometry; Proteome

Indexed keywords

BIOLOGICAL MARKER; HALOTHANE; KETAMINE; PENTOBARBITAL; PROTEOME;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPE; EPITHELIAL LINING FLUID; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG LAVAGE; LUNG TUMOR; MASS SPECTROMETRY; NONHUMAN; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEOMICS; RABBIT;

EID: 49449100920     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1643     Document Type: Article

References (55)

1. Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest 2006; 130:567-574
2. Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology 2003; 8:432-446
3. Wattiez R, Falmagne P. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815:169-178
4. Bowler RP, Duda B, Chan ED, et al. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1095-L1104
5. Wattiez R, Noel-Georis I, Cruyt C, et al. Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of mice. Proteomics 2003; 3:658-665
6. Plymoth A, Lofdahl CG, Ekberg-Jansson A, et al. Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 2003; 3:962-972
7. He C. Proteomic analysis of human bronchoalveolar lavage fluid: expression profiling of surfactant-associated protein A isomers derived from human pulmonary alveolar proteinosis using immunoaffinity detection. Proteomics 2003; 3:87-94
8. Noel-Georis I, Bernard A, Falmagne P, et al. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 771:221-236
9. Sabounchi-Schutt F, Astrom J, Eklund A, et al. Detection and identification of human bronchoalveolar lavage proteins using narrow-range immobilized pH gradient DryStrip and the paper bridge sample application method. Electrophoresis 2001; 22:1851-1860
10. Noel-Georis I, Bernard A, Falmagne P, et al. Proteomics as the tool to search for lung disease markers in bronchoalveolar lavage. Dis Markers 2001; 17:271-284
11. Wattiez R, Hermans C, Cruyt C, et al. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis 2000; 21:2703-2712
12. Wattiez R, Hermans C, Bernard A, et al. Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis 1999; 20:1634-1645
13. Lindahl M, Svartz J, Tagesson C. Demonstration of different forms of the anti-inflammatory proteins lipocortin-1 and Clara cell protein-16 in human nasal and bronchoalveolar lavage fluids. Electrophoresis 1999; 20:881-890
14. Lindahl M, Stahlbom B, Tagesson C. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: potential biomedical and clinical applications. Electrophoresis 1999; 20:3670-3676
15. Zedtwitz-Liebenstein K, Schenk P, Apfalter P, et al. Ventilator- associated pneumonia: increased bacterial counts in bronchoalveolar lavage by using urea as an endogenous marker of dilution. Crit Care Med 2005; 33:756-759
16. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60:532-538
17. Kipnis E. Using urea as an endogenous marker of bronchoalveolar lavage dilution [letter]. Crit Care Med 2005; 33:2153
18. Feng NH, Hacker A, Effros RM. Solute exchange between the plasma and epithelial lining fluid of rat lungs. J Appl Physiol 1992; 72:1081-1089
19. Ishizaka A, Watanabe M, Yamashita T, et al. New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 2001; 29:896-898
20. Watanabe M, Ishizaka A, Ikeda E, et al. Contributions of bronchoscopic microsampling in the supplemental diagnosis of small peripheral lung carcinoma. Ann Thorac Surg 2003; 76:1668-1672
21. Ishizaka A, Matsuda T, Albertine KH, et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1088-L1094
22. Yamazaki K, Ogura S, Ishizaka A, et al. Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med 2003; 168:1304-1307
23. Rosenfeld J, Capdevielle J, Guillemot JC, et al. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992; 203:173-179
24. Becker KG, Hosack DA, Dennis G, et al. PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 2003; 4:61
25. Lynn AJ, Chalkley RJ, Baker PR, et al. Protein Prospector and ways of calculating expectation values. Paper presented at: 54th American Society for Mass Spectrometry Conference of Mass Spectrometry and Allied Topics; May 28 to June 1, 2006; Seattle, WA
26. Bowler RP, Duda B, Chan ED, et al. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1095-L1104
27. Wattiez R, Falmagne P. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815:169-178
28. Heckel K, Kiefmann R, Dorger M, et al. Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 287:L867-L878
29. Chuchalin AG, Novoselov VI, Shifrina ON, et al. Peroxiredoxin VI in human respiratory system. Respir Med 2003; 97:147-151
30. Lehtonen ST, Markkanen PM, Peltoniemi M, et al. Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. Am J Physiol Lung Cell Mol Physiol 2005; 288:L997-L1001
31. Kinnula VL, Paakko P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004; 569:1-6
32. Rahman Q, Abidi P, Afaq F, et al. Glutathione redox system in oxidative lung injury. Crit Rev Toxicol 1999; 29:543-568
33. Kayser K, Dunnwald D, Kazmierczak B, et al. Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas. Pathol Res Pract 2003; 199:589-598
34. Breen EC, Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003; 88:848-854
35. Arora K, Gwinn WM, Bower MA, et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 2005; 175:517-522
36. Yang H, Chen J, Yang J, et al. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. Biochem Biophys Res Commun 2007; 361:763-767
37. Tegeder I, Schumacher A, John S, et al. Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol 1997; 17:380-386
38. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91:1487-1500
39. Plymoth A, Löfdahl CG, Ekberg-Jansson A, et al. Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 2003; 3:962-972
40. Noel-Georis I, Bernard A, Falmagne P, et al. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 771:221-236
41. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1:845-867
42. Pham LH, Brun-Buisson C, Legrand P, et al. Diagnosis of nosocomial pneumonia in mechanically ventilated patients: comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 1991; 143:1055-1061
43. Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995; 152:1982-1991
44. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-420
45. Marik PE, Careau P. A comparison of mini-bronchoalveolar lavage and blind-protected specimen brush sampling in ventilated patients with suspected pneumonia. J Crit Care 1998; 13:67-72
46. Bregeon F, Papazian L, Thomas P, et al. Diagnostic accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia. Eur Respir J 2000; 16:969-975
47. Flanagan PG, Findlay GP, Magee JT, et al. The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages. Intensive Care Med 2000; 26:20-30
48. Arora SC, Mudaliar YM, Lee C, et al. Non-bronchoscopic bronchoalveolar lavage in the microbiological diagnosis of pneumonia in mechanically ventilated patients. Anaesth Intensive Care 2002; 30:11-20
49. Vyas R, Tudor G, Rickett A, et al. Serial bronchoalveolar lavage of preterm infants is not associated with chest radiological changes. Eur J Pediatr 2002; 161:313-318
50. McNamara PS, Ritson P, Selby A, et al. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003; 88:922-926
51. Mentec H, May-Michelangeli L, Rabbat A, et al. Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia: a multicentre prospective study. Intensive Care Med 2004; 30:1319-1326
52. Brun-Buisson C, Fartoukh M, Lechapt E, et al. Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilator-associated pneumonia. Chest 2005; 128:533-544
53. Labenne M, Poyart C, Rambaud C, et al. Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med 1999; 27:2537-2543
54. Burmester M, Mok Q. How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children? Intensive Care Med 2001; 27:716-721
55. Casetta M, Blot F, Antoun S, et al. Diagnosis of nosocomial pneumonia in cancer patients undergoing mechanical ventilation: a prospective comparison of the plugged telescoping catheter with the protected specimen brush. Chest 1999; 115:1641-1645